Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Astrana Health Affirms FY2025 Sales Guidance of $2.50B-$2.70B vs $2.73B Est

Author: Benzinga Newsdesk | May 08, 2025 03:25pm

Astrana Health (NASDAQ:ASTH) affirms FY2025 sales outlook from $2.50 billion-$2.70 billion to $2.50 billion-$2.70 billion vs $2.73 billion estimate.

Posted In: ASTH